Klaviyo Inc’s filing revealed that its Officer LANDON RAMON EDMOND acquired Company’s shares for reported $0.24 million on Mar 03 ’25. In the deal valued at $39.32 per share,6,222 shares were bought.
Then, Galvin Carmel sold 11,531 shares, generating $465,107 in total proceeds. Upon selling the shares at $40.34, the Chief People Officer now owns 617,706 shares.
Before that, Galvin Carmel bought 11,531 shares. Klaviyo Inc shares valued at $477,960 were divested by the Officer at a price of $41.45 per share.
Loop Capital reiterated its Klaviyo Inc [KVYO] rating to a Buy in a research note published on December 23, 2024; the price target was $60. A number of analysts have revised their coverage, including Macquarie’s analysts, who began to cover the stock in late October with a ‘”a Neutral”‘ rating. Stifel began covering KVYO with “Buy” recommendation on October 22, 2024. Wells Fargo started covering the stock on October 16, 2024. It rated KVYO as “an Equal weight”.
Price Performance Review of KVYO
On Monday, Klaviyo Inc [NYSE:KVYO] saw its stock fall -2.62% to $38.29. Over the last five days, the stock has lost -7.89%. Klaviyo Inc shares have fallen nearly -7.15% since the year began. Nevertheless, the stocks have risen 37.59% over the past one year. While a 52-week high of $49.55 was reached on 02/11/25, a 52-week low of $21.26 was recorded on 03/03/25. SMA at 50 days reached $43.45, while 200 days put it at $33.95.
Levels Of Support And Resistance For KVYO Stock
The 24-hour chart illustrates a support level at 37.49, which if violated will result in even more drops to 36.68. On the upside, there is a resistance level at 39.55. A further resistance level may holdings at 40.80. The Relative Strength Index (RSI) on the 14-day chart is 28.93, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.99%. Stochastics %K at 5.73% indicates the stock is a buying.
The most recent change occurred on September 30, 2024 when The Benchmark Company began covering the stock and recommended ‘”a Buy”‘ rating along with a $42 price target.
